HyperWeb‘s lead financial expert reviewed the latest report from Northrop Grumman, which raised its outlook for the year. Sales climbed about seven percent to just over $11 billion, and shares gained more than 4%. Record orders drove the mood, yet the details call for a closer read.

Orders ran about 1.5 times sales, a ratio known as book-to-bill. A reading above 1.0 means new business is arriving faster than the company can deliver it. Backlog reached a record $109.6 billion at quarter end.

Orders at 1.5 Times Sales

Net awards totaled $16.4 billion in the quarter. Backlog is up 15% from $95.7 billion at the end of last year. That adds roughly $14 billion in nine months.

Five awards account for $10.3 billion, or 63% of the total. The largest were $4.6 billion in restricted programs and $2.0 billion for the Sentinel missile. Virginia Class submarines added $1.4 billion, the F-35 added $1.3 billion, and the E-2 added $1.0 billion.

The remaining $6.1 billion came from smaller contracts. Large programs therefore set the pace of order flow, though the mix spans aircraft, missiles, and ships.

Two Segments Carry the Growth

Aeronautics Systems grew 14% to $3.58 billion on F-35 production timing, higher B-21 bomber sales, plus B-2 sustainment. Operating income in that segment rose 24%. Defense Systems rose 12% to $2.31 billion as the Sentinel program ramped, adding $180 million.

Mission Systems and Space Systems grew just 2% each. Two of four segments therefore produced the gain.

Working back from those growth rates, Aeronautics added about $440 million and Defense Systems about $250 million. Together, that is roughly 95% of the company’s $730 million increase. These are estimates from rounded figures.

Aeronautics operating income rose 24%, yet the company total rose only 2%. Other segments or corporate items must have absorbed much of that gain. The release breakdown shows where.

Profit Lags Revenue

Per-share profit came in at $7.89, up roughly 3%. Operating income grew only 2%, and the margin slipped to 11.4% from 11.9%. Profit growth therefore trailed sales growth.

On roughly $11 billion of sales, that margin puts operating income near $1.27 billion. This is an estimate from rounded figures. The company reports the exact amount in its release.

Management blames a $52 million drop in pension-related accounting income. That item reflects cost allocation, not program performance.

Tax also helped. The effective rate fell to 13.4% from 16.9% on larger research benefits. On the same pretax profit, that drop lifts net earnings by about 4%, above the 3% growth reported.

Share count and other items also move per-share results, so treat this as a rough guide. Still, underlying earnings growth looks close to flat here.

Cash Flow Without the One-Off

Cash after capital spending, on the company’s adjusted basis, came to about $1.8 billion, up 44%. A $371 million equipment sale to a customer is part of that total. Removing it leaves about $1.44 billion.

The cleaner $1.44 billion still beats last year’s $1.26 billion by about 15%. Operating cash flow rose 12% on better working capital. Those swings can reverse in later quarters, so one strong quarter deserves caution.

The nine-month total stands at $965 million. The full-year goal centers near $3.3 billion, so the final quarter must deliver roughly $2.3 billion. That is about 1.6 times the clean third-quarter figure.

Funded Versus Unfunded

Backlog dollars differ in their certainty. Funded orders total $50.1 billion, and unfunded orders total $59.5 billion. The unfunded share is about 54%.

Funded means Congress has appropriated the money. Unfunded work depends on future budget decisions. A shutdown or long stopgap bill could slow conversion of backlog into sales.

Defense Systems backlog grew 31% to $36.5 billion this year. About $26.2 billion of it, roughly 72%, is unfunded. That segment carries the heaviest budget exposure of the four.

Guidance Moves Up

Segment operating income guidance now centers near $5 billion. The per-share profit outlook centers near $29.55, which is 70 cents above the old center. Sales guidance centers near $44 billion.

Those centers imply a segment margin near 11.3%, close to this quarter’s 11.4%. Cash flow guidance centers near $3.3 billion for the year. Aeronautics and Mission Systems margin guidance edged up, while Defense Systems and Space Systems held steady.

Raising guidance after a strong report lifts the bar. Management now has less room for a soft finish.

What Allocators Should Weigh

The report supports the long-term demand case for aerospace and defense exposure. Budget timing is the main risk, so position sizing should reflect that dependence. A stock that gains more than 4% in a session has already priced in some good news.

Staged entries can reduce timing risk. The final-quarter cash target deserves a close watch. A miss would not break the thesis, but it would test the full-year number.